BACKGROUND: Little is known about the rates of cardiovascular disease (CVD), atherosclerosis, and their risk factors among Canada's Aboriginal people. To establish the relative prevalence of risk factors, atherosclerosis, and CVD, we undertook a population-based study among people of Aboriginal and European ancestry in Canada. METHODS: We randomly recruited 301 Aboriginal people from the Six Nations Reservation, and 326 people of European origin from Hamilton, Toronto, and Edmonton, Canada. Clinical CVD was defined by history or electrocardiographic findings, atherosclerosis was measured by B-mode carotid ultrasonography, and conventional and new CVD risk factors were measured using standardised methods. FINDINGS: Aboriginal people had significantly more carotid atherosclerosis (mean of the maximum intimal-medial thickness 0.82 (SD 0.20) mm vs 0.78 (0.20) mm, p=0.027), and had a higher frequency of CVD (18.5% vs 7.6%, p=0.00002) compared with Europeans. Aboriginal people had significantly higher rates of smoking, glucose intolerance, obesity, abdominal obesity, and substantially higher concentrations of fibrinogen, and plasminogen activator inhibitor-1. Aboriginal people had significantly higher rates of unemployment and a lower annual household income. For any given income level, Aboriginal people had higher rates of risk factors and CVD compared with the Europeans. INTERPRETATION: A significant proportion of Aboriginal people live in poverty which is associated with high rates of CVD and CVD risk factors. Improvement of the socioeconomic status of Aboriginal people might be a key to reduce CVD in this group.
BACKGROUND: Little is known about the rates of cardiovascular disease (CVD), atherosclerosis, and their risk factors among Canada's Aboriginal people. To establish the relative prevalence of risk factors, atherosclerosis, and CVD, we undertook a population-based study among people of Aboriginal and European ancestry in Canada. METHODS: We randomly recruited 301 Aboriginal people from the Six Nations Reservation, and 326 people of European origin from Hamilton, Toronto, and Edmonton, Canada. Clinical CVD was defined by history or electrocardiographic findings, atherosclerosis was measured by B-mode carotid ultrasonography, and conventional and new CVD risk factors were measured using standardised methods. FINDINGS: Aboriginal people had significantly more carotid atherosclerosis (mean of the maximum intimal-medial thickness 0.82 (SD 0.20) mm vs 0.78 (0.20) mm, p=0.027), and had a higher frequency of CVD (18.5% vs 7.6%, p=0.00002) compared with Europeans. Aboriginal people had significantly higher rates of smoking, glucose intolerance, obesity, abdominal obesity, and substantially higher concentrations of fibrinogen, and plasminogen activator inhibitor-1. Aboriginal people had significantly higher rates of unemployment and a lower annual household income. For any given income level, Aboriginal people had higher rates of risk factors and CVD compared with the Europeans. INTERPRETATION: A significant proportion of Aboriginal people live in poverty which is associated with high rates of CVD and CVD risk factors. Improvement of the socioeconomic status of Aboriginal people might be a key to reduce CVD in this group.
Authors: Anna Chu; Lu Han; Idan Roifman; Douglas S Lee; Michael E Green; Kristen Jacklin; Jennifer Walker; Roseanne Sutherland; Shahriar Khan; Eliot Frymire; Jack V Tu; Baiju R Shah Journal: CMAJ Date: 2019-11-25 Impact factor: 8.262
Authors: Song Gao; Braden J Manns; Bruce F Culleton; Marcello Tonelli; Hude Quan; Lynden Crowshoe; William A Ghali; Lawrence W Svenson; Sofia Ahmed; Brenda R Hemmelgarn Journal: CMAJ Date: 2008-11-04 Impact factor: 8.262
Authors: Andrew Mente; Fahad Razak; Stefan Blankenberg; Vlad Vuksan; A Darlene Davis; Ruby Miller; Koon Teo; Hertzel Gerstein; Arya M Sharma; Salim Yusuf; Sonia S Anand Journal: Diabetes Care Date: 2010-04-22 Impact factor: 19.112
Authors: Sheldon W Tobe; Joan Wentworth; Laurie Ironstand; Susan Hartman; Jackie Hoppe; Judi Whiting; Janice Kennedy; Colin McAllister; Alex Kiss; Nancy Perkins; Lloyd Vincent; George Pylypchuk; Richard Z Lewanczuk Journal: BMC Endocr Disord Date: 2009-05-09 Impact factor: 2.763